Local drug and gene delivery through microbubbles

Progress in Cardiovascular Diseases

Volumn 44, Issue 1, 2001, Pages 45-54

  Unger, Evan C ^a   Hersh, Evan ^a   Vannan, Mani ^a   Matsunaga, Terry O ^a   McCreery, Thomas ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DMRIE DOPE; DRUG VEHICLE; ECHO CONTRAST MEDIUM; RECOMBINANT CYTOKINE; UNCLASSIFIED DRUG;

ARTICLE; BUBBLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENERGY TRANSFER; GENE EXPRESSION REGULATION; GENE TARGETING; HEART MUSCLE; HUMAN; INTRACELLULAR TRANSPORT; MOLECULAR BIOLOGY; OXYGENATOR; PHYSICAL CHEMISTRY; SHOCK; TECHNOLOGY; ULTRASOUND;

EID: 0034860986     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2001.26443     Document Type: Article

References (50)

1. Local and systemic evidence for VEGF production after direct intramyocardial injection with naked DNA encoding for VEGF
2. Constitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
3. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury
4. Gene therapy inhibiting neointimal vascular lesion formation: In vivo transfer of endothelial cell nitric oxide synthase gene
5. Molecular biology and gene transfer in atherosclerosis in the stenting era
6. Copper deficiency and heart disease: Molecular basis, recent advances and current concepts
7. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
8. Gene therapy for myocardial angiogenesis
9. Review article: Gene therapy in gastroenterology and hepatology
10. Molecular Cardiovascular Medicine
11. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
12. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound
13. Phase I clinical trials of MRX-115. A new ultrasound contrast agent
14. Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist
15. Echo-enhancing ("contrast") agents for ultrasound
16. Physics of ultrasound contrast agents
17. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound
18. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective
19. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue
20. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound
21. Metabolic instability of plasmid DNA in the cytosol: A potential barrier to gene transfer
22. Uptake by rat liver and intracellular fate of plasmid DNA complexed with poly-L-lysine or poly-D-lysine
23. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle
24. Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine
25. Regulated expression of a foreign gene targeted to the ischaemic myocardium
26. Direct gene transfer to mouse melanoma by intratumor injection of free DNA
27. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity
28. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery
29. Gene transfer mediated by YKS-220 cationic particles: Convenient and efficient gene delivery
30. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
31. Intratumoral delivery of IL- 12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity
32. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
33. A novel potent strategy for gene delivery using a single peptide vector as a carrier
34. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: Implication for gene therapy
35. Rac continues searching for cause of gene therapy death
36. Ultrasound enhancement of gene expression and gene delivery using acoustically active carriers
37. Ultrasound enhanced gene expression and gene delivery
38. Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
39. MRX 501: A novel ultrasound contrast agent with therapeutic properties
40. Ultrasound enhancement of gene expression from liposomal transfection
41. Ultrasound enhances gene expression of liposomal transfection
42. Therapeutic applications of microbubbles
43. Intravenous antisense administered bound to perfluorocarbon exposed sonicated dextrose albumin microbubbles inhibits stenosis formation following coronary balloon injury
44. Ultrasound power affects uptake of PESDA linked oligonucleotide deposition into myocardial tissue
45. The effect of microbubble gas composition and external ultrasound frequency on the non-invasive enhancement of antisense oligonucleotide delivery to the vascular wall in pigs
46. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles
47. Ultrasound-mediated transfection with cationic gelatin
48. In vivo transfection and gene expression in canine myocardium after intravenous injection of microbubble linked plasmid DNA and exposure to ultrasound